Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
PLoS One. 2020 Sep 21;15(9):e0238620. doi: 10.1371/journal.pone.0238620. eCollection 2020.
Despite careful patient selection, successful recanalization in intravenous thrombolysis is only achieved in approximately 50% of cases. Understanding changes in cerebral autoregulation during and following successful recanalization in acute ischemic stroke patients who receive intravenous thrombolysis, may inform the management of common physiological perturbations, including blood pressure, in turn reducing the risk of reperfusion injury. Cerebral blood velocity (Transcranial Doppler), blood pressure (Finometer) and end-tidal carbon dioxide (capnography) were continuously recorded in 11 acute ischemic stroke patients who received intravenous thrombolysis (5 female, mean ± SD age 68±12 years) over 4-time points, during and at the following time intervals after intravenous thrombolysis: 23.9±2.6 hrs, 18.1±7.0 days and 89.6±4.2 days. Reductions in blood pressure (p = 0.04) were observed during intravenous thrombolysis. Reductions in heart rate (p<0.005) and critical closing pressure [Affected hemisphere (p = 0.02) and non-affected hemisphere (p<0.005)] were observed post intravenous thrombolysis. End-tidal CO2 increased during the sub-acute and chronic stages (p = 0.028). Reduction in affected hemisphere phase at low frequency was observed during intravenous thrombolysis (p = 0.021) and at subsequent visits (p = 0.048). No changes were observed in cerebral blood velocity, coherence, gain and Autoregulation Index during the follow-up period. Intravenous thrombolysis in acute ischemic stroke patients induced changes in affected hemisphere phase and other key hemodynamic parameters, but not Autoregulation Index. Further investigation of cerebral autoregulation is warranted in a larger acute ischemic stroke cohort to inform its potential role in individualized management plans.
尽管进行了仔细的患者选择,但在接受静脉溶栓治疗的急性缺血性卒中患者中,仅有约 50%的患者能够实现再通。了解接受静脉溶栓治疗的急性缺血性卒中患者再通过程中和再通后脑自动调节的变化,可能有助于了解常见生理干扰的处理方法,包括血压,从而降低再灌注损伤的风险。连续记录了 11 名接受静脉溶栓治疗的急性缺血性卒中患者(女性 5 名,平均年龄 68±12 岁)在静脉溶栓治疗期间和治疗后以下四个时间点的脑血流速度(经颅多普勒)、血压(Finometer)和呼气末二氧化碳(二氧化碳描记法):23.9±2.6 小时、18.1±7.0 天和 89.6±4.2 天。在静脉溶栓治疗期间观察到血压下降(p=0.04)。在静脉溶栓治疗后观察到心率下降(p<0.005)和临界关闭压下降[患侧半球(p=0.02)和非患侧半球(p<0.005)]。在亚急性期和慢性期,呼气末二氧化碳增加(p=0.028)。在静脉溶栓治疗期间(p=0.021)和随后的就诊期间(p=0.048)观察到低频时患侧相位减少。在随访期间,脑血流速度、相干性、增益和自动调节指数均无变化。急性缺血性卒中患者静脉溶栓治疗后,患侧相位和其他关键血流动力学参数发生变化,但自动调节指数未发生变化。需要在更大的急性缺血性卒中队列中进一步研究脑自动调节,以了解其在个体化管理计划中的潜在作用。